These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5976996)

  • 1. Maple syrup urine disease in Indian baby: branched chain amino and ketoaciduria.
    Dastur DK; Manghani DK; Joshi MK; Adavi SV
    Indian J Med Res; 1966 Oct; 54(10):915-22. PubMed ID: 5976996
    [No Abstract]   [Full Text] [Related]  

  • 2. Branched chain ketoaciduria (maple syrup urine disease).
    Snyderman SE
    Clin Perinatol; 1976 Mar; 3(1):41-52. PubMed ID: 954344
    [No Abstract]   [Full Text] [Related]  

  • 3. Interrelation between the metabolism of L-isoleucine and L-allo-isoleucine in patients with maple syrup urine disease.
    Wendel U; Langenbeck U; Seakins JW
    Pediatr Res; 1989 Jan; 25(1):11-4. PubMed ID: 2919111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Branched-chain alpha-keto acids for the diagnosis of maple-syrup-urine disease.
    Parsons H; Fung E; Snyder FF
    N Engl J Med; 1987 Apr; 316(15):951. PubMed ID: 3821846
    [No Abstract]   [Full Text] [Related]  

  • 5. Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy.
    Felber SR; Sperl W; Chemelli A; Murr C; Wendel U
    Ann Neurol; 1993 Apr; 33(4):396-401. PubMed ID: 8489211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiamine response in maple syrup urine disease.
    Fernhoff PM; Lubitz D; Danner DJ; Dembure PP; Schwartz HP; Hillman R; Bier DM; Elsas LJ
    Pediatr Res; 1985 Oct; 19(10):1011-6. PubMed ID: 3903643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-onset branched-chain ketoaciduria: (maple syrup urine disease).
    Morris MD; Fisher DA; Fiser R
    J Lancet; 1966 Mar; 86(3):149-52. PubMed ID: 5904649
    [No Abstract]   [Full Text] [Related]  

  • 8. Teaching NeuroImages: MRI in maple syrup urine disease.
    Bindu PS; Kovoor JM; Christopher R
    Neurology; 2010 Jan; 74(3):e12. PubMed ID: 20083792
    [No Abstract]   [Full Text] [Related]  

  • 9. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
    Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical studies in a patient with maple syrup urine disease (author's transl)].
    Vaca G; Rivas F; Sánchez-Corona J; Olivares N; Aguirre-Negrete MG; González-Quiroga G; Medina C; Hernández A; Cantú JM
    Rev Invest Clin; 1981; 33(4):379-82. PubMed ID: 7330511
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical studies on a variant of branched chain ketoaciduria in a 19-year-old female.
    Fischer MH; Gerritsen T
    Pediatrics; 1971 Nov; 48(5):795-801. PubMed ID: 5125877
    [No Abstract]   [Full Text] [Related]  

  • 12. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease.
    McMahon Y; MacDonnell RC
    Adv Perit Dial; 1990; 6():31-4. PubMed ID: 1982835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: Neonatal diagnosis of maple syrup urine disease and the influence of exchange blood transfusion.
    Russell A; Statter M; Shina A; Perlman M
    Isr J Med Sci; 1975 Nov; 11(11):1218-9. PubMed ID: 1205813
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ophthalmological and histopathological findings in maple syrup disease].
    Franke G; Teuscher M; Knapp A; Seidlitz G
    Fortschr Ophthalmol; 1983; 80(6):457-9. PubMed ID: 6662450
    [No Abstract]   [Full Text] [Related]  

  • 15. Ophthalmoplegia and bulbar palsy in variant form of maple syrup urine disease.
    Chhabria S; Tomasi LG; Wong PW
    Ann Neurol; 1979 Jul; 6(1):71-2. PubMed ID: 507761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maple syrup urine disease: diffusion MRI, and proton MR spectroscopy findings.
    Sener RN
    Comput Med Imaging Graph; 2007 Mar; 31(2):106-10. PubMed ID: 17207604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3 patients with maple syrup urine disease].
    Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E
    An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isolated isoleucine deficiency in diet therapy of a case of maple syrup urine disease].
    Sanjurjo P; Centeno C; Vallo A; Ojembarrena E; Rodríguez Soriano J
    An Esp Pediatr; 1983 Nov; 19(5):389-92. PubMed ID: 6660656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of maple syrup urine disease on resin coated chromatosheets.
    Kovács J
    Acta Biochim Biophys Acad Sci Hung; 1979; 14(3):119-21. PubMed ID: 547666
    [No Abstract]   [Full Text] [Related]  

  • 20. Dietary treatment of maple sirup urine disease (branched-chain ketoaciduria).
    Noel MB; Stanley PB; Girz JC; Allen RJ
    J Am Diet Assoc; 1976 Jul; 69(1):62-8. PubMed ID: 932376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.